Bonnie Ky
邦妮·凯
MD, MSCE
Professor of Medicine and Epidemiology, Director of Cardio-Oncology医学与流行病学教授，肿瘤心脏病学主任
👥Biography 个人简介
Pioneer in cardio-oncology at Penn Medicine, Dr. Ky leads research on cardiovascular complications of cancer therapies, particularly trastuzumab and anthracycline-induced cardiomyopathy. She directs the Penn Cardio-Oncology program and has advanced biomarker strategies for early detection of cardiotoxicity.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Penn Cardio-Oncology Program Leadership
Established Penn Cardio-Oncology Program as a national model for multidisciplinary care integrating cardiology and oncology.
Biomarker Research for Cardiotoxicity
Identified novel biomarkers (troponin, BNP) for early detection of chemotherapy-induced cardiotoxicity, enabling timely intervention.
SUCCOR Trial and Cardioprotection
Led landmark SUCCOR trial examining cardioprotection strategies in breast cancer patients receiving anthracyclines and trastuzumab.
Representative Works 代表性著作
Trastuzumab-Related Cardiotoxicity: Calling into Question the Current Criteria
Journal of Clinical Oncology (2013)
Redefined cardiotoxicity criteria for HER2-targeted therapies, influencing monitoring guidelines.
Biomarkers for Cardiotoxicity Prediction in Cancer Patients
JACC: CardioOncology (2021)
Established biomarker framework for cardiac risk surveillance in cancer treatment.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Javid Moslehi
University of California San Francisco (UCSF)
Richard Steingart
Memorial Sloan Kettering Cancer Center
Daniel Lenihan
International CardiOncology Society (ICOS)
Joerg Herrmann
Mayo Clinic
关注 邦妮·凯 的研究动态
Follow Bonnie Ky's research updates
留下邮箱，当我们发布与 Bonnie Ky（Penn Medicine / University of Pennsylvania）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment